3,8-Dibromo-1,10-phenanthroline (1.49 g, 4.4 mmol) and a stirring bar were placed in an autoclave (125 mL) with a PTFE inner vessel and Ni(dppp)Cl2 (138 mg, 6 mol%) and THF (50 mL) were gradually added. A THF solution of (iPrO)3SiCH2MgCl (12.5 mmol) was added dropwise over 3 min under continuous stirring. The autoclave was sealed and stirred at room temperature for 1 h, and then heated to 140 °C. After 17 h, the mixture was cooled to room temperature and then quenched with water. The mixture was extracted with CHCl3 and the organic layer was washed with brine and dried over Na2SO4. The solvents were removed by rotary evaporator. The crude product was dissolved in n-hexane and stirred for 15 min. The mixture was filtered through a Celite pad and the solvent was removed by rotary evaporator. The crude product was purified by silica gel column chromatography (n-hexane/AcOEt) to give the Phen-PMO precursor, 3,8-bis[(triisopropoxysilyl)methyl]-1,10-phenanthroline (1a), as a pale-yellow solid (1.11 g, 41%). 1H NMR (600 MHz, CDCl3): δ 9.00 (d, J = 2.1 Hz, 2H), 8.00 (d, J = 2.1 Hz, 2H), 7.65 (s, 2H), 4.21 (sept, J = 6.1 Hz, 6H), 2.36 (s, 4H), 1.15 ppm (d, J = 6.1 Hz, 36H). 13C{1H} NMR (151 MHz, CDCl3): δ 151.9, 143.9, 134.8, 133.4, 127.9, 126.2, 65.7, 25.7, 19.6 ppm. 29Si{1H} NMR (119 MHz, CDCl3): δ −56.5 ppm. Anal. calcd for C32H52N2O6Si2: C, 62.30; H, 8.50; N, 4.54. Found: C, 62.30; H, 8.90; N, 4.50.